Barutta et al. also showed that the blockade of CB1R along with ACE inhibition treatment can reverse albuminuria and nephron loss while also reducing inflammation in an animal model of T1DM with early diabetic nephropathy, results that could be of use for this complication in human patients [173]. This evidence concerns the gene CNR1 and diabetic kidney disease.